Mortality among amphetamine users with hepatitis C virus infection: A nationwide study.
Caroline GahrtonAnders HåkanssonMartin KåbergAnna JerkemanHenrike HäbelOlav DalgardAnn-Sofi DubergSoo AlemanPublished in: PloS one (2021)
This national register study presents a higher crude risk of liver-related death among HCV-infected amphetamine users compared with opioid users or the uninfected general population. The higher risk of liver-related death compared with opioid users may be explained by lower competing death risk and higher alcohol consumption. Treatment of HCV infection and alcohol use disorders are needed to reduce the high liver-related mortality.